priligy equivalent Tamoxifen, raloxifene, and aromatase inhibitors all reduce primary breast cancer risk in postmenopausal women Use of raloxifene and aromatase inhibitors is indicated only in postmenopausal women Only tamoxifen is indicated for risk reduction of primary breast cancer in premenopausal women
1 Comment
Elavielay
28 Ağustos 2024 at 18:59priligy equivalent Tamoxifen, raloxifene, and aromatase inhibitors all reduce primary breast cancer risk in postmenopausal women Use of raloxifene and aromatase inhibitors is indicated only in postmenopausal women Only tamoxifen is indicated for risk reduction of primary breast cancer in premenopausal women